Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:
If someone tries to reset your password, you will be informed immediately
Only you will receive email & sms alerts relating to your stocks & overall portfolio
Opted-in market updates, news, research reports, will be delivered to you on-time
Centrum has come out with its second quarter (July-September) earnings estimates for the Pharmaceuticals sector. The brokerage house expects FDC to report net profit at Rs 56.8 crore, up 3.5 percent quarter-on-quarter.
Net Sales are expected to increase by 4.7 percent Q-o-Q (up 6.8 percent Y-o-Y) to Rs 277 crore, according to Centrum.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 5 percent Q-o-Q (up 19.3 percent Y-o-Y) to Rs 71.5 crore.
Centrum's report on FDC
We expect FDC to report revenue growth of 7% YoY and 5% QoQ to Rs 2.77bn led by good performance of its flagship brands Zifi & its line extensons and Enerzal. These brands contribute 32% to the company’s revenues and are likely to be growth drivers.
We expect FDC’s net profit to grow by 23% YoY to Rs568mn from Rs461mn.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.